Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in Cigna Group (NYSE:CI - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 13,842 shares of the health services provider's stock, valued at approximately $3,816,000.
Several other large investors have also recently bought and sold shares of CI. Wilkerson Advisory Group LLC acquired a new stake in shares of Cigna Group during the 4th quarter worth about $25,000. Cedar Mountain Advisors LLC increased its stake in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock worth $29,000 after buying an additional 68 shares during the period. Johnson Financial Group Inc. acquired a new stake in shares of Cigna Group during the second quarter valued at about $29,000. Kemnay Advisory Services Inc. acquired a new position in shares of Cigna Group in the 4th quarter valued at approximately $29,000. Finally, Prosperity Bancshares Inc acquired a new stake in shares of Cigna Group during the fourth quarter worth approximately $29,000. Hedge funds and other institutional investors own 86.99% of the company's stock.
Insider Activity
In other news, CAO Jamie G. Kates sold 899 shares of the business's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares of the company's stock, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 23,012 shares of company stock valued at $6,386,550 in the last three months. 0.60% of the stock is owned by insiders.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a "buy" rating to a "hold" rating and lowered their price target for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Wolfe Research restated an "outperform" rating and set a $315.00 price objective on shares of Cigna Group in a research note on Tuesday, June 16th. Mizuho boosted their target price on shares of Cigna Group from $330.00 to $340.00 and gave the company an "outperform" rating in a research note on Monday, June 8th. Sanford C. Bernstein lifted their price target on shares of Cigna Group from $371.00 to $381.00 and gave the company an "outperform" rating in a report on Thursday, July 9th. Finally, The Goldman Sachs Group raised their target price on shares of Cigna Group from $335.00 to $340.00 and gave the stock a "buy" rating in a report on Monday, May 4th. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group presently has an average rating of "Moderate Buy" and a consensus price target of $339.45.
Read Our Latest Stock Analysis on CI
Cigna Group Price Performance
CI opened at $280.32 on Tuesday. The firm has a market capitalization of $74.07 billion, a P/E ratio of 11.60, a PEG ratio of 0.95 and a beta of 0.29. The stock has a fifty day moving average of $283.92 and a 200-day moving average of $281.48. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47.
Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. The company had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company's revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities analysts forecast that Cigna Group will post 30.51 EPS for the current fiscal year.
Cigna Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group's dividend payout ratio (DPR) is currently 25.82%.
Cigna Group Profile
(
Free Report)
Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
